By Professor Jerry Richard Greenfield

Journal articles

Sheu A; Greenfield JR; White CP; Center JR, 2022, 'Assessment and treatment of osteoporosis and fractures in type 2 diabetes', Trends in Endocrinology and Metabolism, 33, pp. 333 - 344, http://dx.doi.org/10.1016/j.tem.2022.02.006

Raven LM; Mccormack AI; Greenfield JR, 2022, 'Letter to the Editor From Raven et al: "Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine"', Journal of Clinical Endocrinology and Metabolism, 107, pp. E1767 - E1768, http://dx.doi.org/10.1210/clinem/dgab822

Lasschuit JWJ; Greenfield JR; Tonks KTT, 2022, 'Contribution of peripheral neuropathy to poor bone health in the feet of people with type 2 diabetes mellitus', Acta Diabetologica, 59, pp. 217 - 224, http://dx.doi.org/10.1007/s00592-021-01803-w

Bennett MJ; Balcerek MI; Lewis EAD; Zhang RLL; Bachmeier C; Tey S; Faux S; Girgis L; Greenfield JR; Lazarus S; Bennett M, 2022, 'Voriconazole-Associated Periostitis: New Insights into Pathophysiology and Management', JBMR Plus, 6, pp. e10557, http://dx.doi.org/10.1002/jbm4.10557

Dahiya S; Tisch S; Greenfield J, 2022, 'The effect of GLP-1 receptor agonists in pre-clinical rodent models of Parkinson's disease: A systematic review and meta-analysis', Clinical Parkinsonism and Related Disorders, 6, http://dx.doi.org/10.1016/j.prdoa.2022.100133

Milder T; Stocker S; Baysari M; Day R; Greenfield J, 2022, 'Prescribing of SGLT2 Inhibitors in Clinical Practice: A Qualitative Study of Cardiologists', Heart, Lung and Circulation, 31, pp. S96 - S97, http://dx.doi.org/10.1016/j.hlc.2022.06.117

Chavali S; Muthiah K; Hayward C; Macdonald P; Robson D; Greenfield J; Raven L, 2022, 'Safety and Tolerability of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Patients Supported With Left Ventricular Assist Devices', Heart, Lung and Circulation, 31, pp. S100 - S100, http://dx.doi.org/10.1016/j.hlc.2022.06.124

Snaith JR; Danta M; Greenfield JR, 2021, 'Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes', The Lancet Gastroenterology and Hepatology, 6, pp. 985 - 986, http://dx.doi.org/10.1016/S2468-1253(21)00343-5

Watt KI; Henstridge DC; Ziemann M; Sim CB; Montgomery MK; Samocha-Bonet D; Parker BL; Dodd GT; Bond ST; Salmi TM; Lee RS; Thomson RE; Hagg A; Davey JR; Qian H; Koopman R; El-Osta A; Greenfield JR; Watt MJ; Febbraio MA; Drew BG; Cox AG; Porrello ER; Harvey KF; Gregorevic P, 2021, 'Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease', Nature Communications, 12, http://dx.doi.org/10.1038/s41467-021-23240-7

Milder TY; Stocker SL; Baysari M; Day RO; Greenfield JR, 2021, 'Prescribing of SGLT2 inhibitors in primary care: A qualitative study of General Practitioners and Endocrinologists', Diabetes Research and Clinical Practice, 180, http://dx.doi.org/10.1016/j.diabres.2021.109036

Perera CJ; Falasca M; Chari ST; Greenfield JR; Xu Z; Pirola RC; Wilson JS; Apte MV, 2021, 'Role of pancreatic stellate cell-derived exosomes in pancreatic cancer-related diabetes: A novel hypothesis', Cancers, 13, pp. 5224, http://dx.doi.org/10.3390/cancers13205224

Heidegger DP; Neal KE; Patel SK; Greenfield JR; Tonks KT, 2021, 'Effect of fasting ketosis and type 1 diabetes on alcohol breath analysis technology used in Australia', Internal Medicine Journal, 51, pp. 1555 - 1556, http://dx.doi.org/10.1111/imj.15488

Snaith JR; Samocha-Bonet D; Evans J; Liu Z; Kowalski G; Bruce C; Holmes-Walker DJ; Greenfield JR, 2021, 'Insulin resistance in type 1 diabetes managed with metformin (INTIMET): Study protocol of a double-blind placebo-controlled, randomised trial', Diabetic Medicine, 38, http://dx.doi.org/10.1111/dme.14564

Milder T; Stocker S; Baysari M; Day RO; Greenfield J, 2021, 'Prescribing of SGLT2 Inhibitors in Primary Care: A Qualitative Study of Primary Care Physicians and Endocrinologists', DIABETES, 70, http://dx.doi.org/10.2337/db21-779-P

Patel SK; Ma CS; Fourlanos S; Greenfield JR, 2021, 'Autoantibody-Negative Type 1 Diabetes: A Neglected Subtype', Trends in Endocrinology and Metabolism, 32, pp. 295 - 305, http://dx.doi.org/10.1016/j.tem.2021.02.001

Patel SK; Fourlanos S; Greenfield JR, 2021, 'Comment on ‘impact of routine Clinic Measurement of random Serum c-peptide in people with a Clinician Diagnosis of type 1 diabetes’', Diabetic Medicine, 38, http://dx.doi.org/10.1111/dme.14513

Bishay RH; Tonks KT; George J; Samocha-Bonet D; Meyerowitz-Katz G; Chisholm DJ; James DE; Greenfield JR, 2021, 'Plasma Bile Acids More Closely Align with Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity', Journal of Clinical Endocrinology and Metabolism, 106, pp. E1131 - E1139, http://dx.doi.org/10.1210/clinem/dgaa940

Milder TY; Stocker SL; Day RO; Greenfield JR, 2020, 'Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease', Drug Safety, 43, pp. 1211 - 1221, http://dx.doi.org/10.1007/s40264-020-01010-6

Lasschuit JWJ; Center JR; Greenfield JR; Tonks KTT, 2020, 'Comparison of calcaneal quantitative ultrasound and bone densitometry parameters as fracture risk predictors in type 2 diabetes mellitus', Diabetic Medicine, 37, pp. 1902 - 1909, http://dx.doi.org/10.1111/dme.14183

Htet TD; Godneva A; Liu Z; Chalmers E; Kolobkov D; Snaith JR; Richens R; Toth K; Danta M; Hng TM; Elinav E; Segal E; Greenfield JR; Samocha-Bonet D, 2020, 'Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin', BMJ Open, 10, pp. e037859, http://dx.doi.org/10.1136/bmjopen-2020-037859

Snaith JR; Holmes-Walker DJ; Greenfield JR, 2020, 'Letter to the editor: ⇜risk factors for cardiovascular disease (CVD) in adults with type 1 diabetes: findings from prospective real-life T1D exchange registry”', Journal of Clinical Endocrinology and Metabolism, 105, pp. 1 - 2, http://dx.doi.org/10.1210/clinem/dgaa383

Hussain I; Jin RR; Baum HBA; Greenfield JR; Devery S; Xing C; Hegele RA; Carranza-Leon BG; Linton MF; Vuitch F; Wu KHC; Precioso DR; Oshima J; Agarwal AK; Garg A, 2020, 'Multisystem progeroid syndrome with lipodystrophy, cardiomyopathy, and nephropathy due to an LMNA p.R349W variant', Journal of the Endocrine Society, 4, http://dx.doi.org/10.1210/jendso/bvaa104

Martin C; Ait Boudaoud A; Poghosyan T; Zhu J; Larger E; Greenfield JR; Czernichow S; Rives-Lange C; Carette C, 2020, 'Prevalence of anti-GAD and IA2 autoantibodies in a French cohort of patients with diabetes eligible for bariatric surgery', Diabetes and Metabolism, 46, pp. 407 - 409, http://dx.doi.org/10.1016/j.diabet.2019.12.004

Snaith JR; Greenfield JR, 2020, 'COVID-19: it's changed us', Internal Medicine Journal, 50, pp. 1162 - 1163, http://dx.doi.org/10.1111/imj.14968

Muir CA; Jones GRD; Greenfield JR; Weissberger A; Samaras K, 2020, 'THYROID PEROXIDASE ANTIBODY POSITIVITY IS ASSOCIATED with RELAPSE-FREE SURVIVAL following ANTITHYROID DRUG TREATMENT for GRAVES DISEASE', Endocrine Practice, 26, pp. 1026 - 1030, http://dx.doi.org/10.4158/EP-2020-0035

Mortimer B; Naganur VD; Satouris P; Greenfield JR; Torpy DJ; Rushworth RL, 2020, 'Acute illness in patients with concomitant Addison's disease and type 1 diabetes mellitus: Increased incidence of hypoglycaemia and adrenal crises', Clinical Endocrinology, 93, pp. 104 - 110, http://dx.doi.org/10.1111/cen.14219

Lasschuit JWJ; Greenfield JR; Tonks KT, 2020, 'High Risk Foot Service reduces number of Emergency Department presentations and length of stay', Diabetes and Metabolism, 46, pp. 252 - 255, http://dx.doi.org/10.1016/j.diabet.2018.07.002

Snaith JR; Samocha-Bonet D; Holmes-Walker DJ; Greenfield JR, 2020, 'MON-LB113 Insulin Resistance in Type 1 Diabetes Managed With Metformin (INTIMET): Rationale and Study Design of a Randomised Placebo-Controlled Trial', Journal of the Endocrine Society, 4, http://dx.doi.org/10.1210/jendso/bvaa046.2038

Muir CA; Greenfield JR; Weissberger A; Jones GRD; Samaras K, 2020, 'SAT-LB75 Thyroid Peroxidase Antibody Positivity Predicts Relapse Free Survival Following Anti-Thyroid Drug Treatment for Graves Disease', Journal of the Endocrine Society, 4, http://dx.doi.org/10.1210/jendso/bvaa046.2016

Milder TY; Day RO; Stocker SL; Greenfield JR, 2020, 'Should the cardio-protective properties of sodium-glucose cotransporter 2 inhibitors dictate therapeutic decision-making in patients with type 2 diabetes', Internal Medicine Journal, 50, pp. 645 - 646, http://dx.doi.org/10.1111/imj.14819

Smith FC; Stocker SL; Danta M; Carland JE; Kumar SS; Liu Z; Greenfield JR; Braithwaite HE; Cheng TS; Graham GG; Williams KM; Day RO, 2020, 'The safety and pharmacokinetics of metformin in patients with chronic liver disease', Alimentary Pharmacology and Therapeutics, 51, pp. 565 - 575, http://dx.doi.org/10.1111/apt.15635

Snaith JR; Holmes-Walker DJ; Greenfield JR, 2020, 'Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?', Trends in Endocrinology and Metabolism, 31, pp. 150 - 164, http://dx.doi.org/10.1016/j.tem.2019.11.007

Harari A; Coster ACF; Jenkins A; Xu A; Greenfield JR; Harats D; Shaish A; Samocha-Bonet D, 2020, 'Obesity and Insulin Resistance Are Inversely Associated with Serum and Adipose Tissue Carotenoid Concentrations in Adults', Journal of Nutrition, 150, pp. 38 - 46, http://dx.doi.org/10.1093/jn/nxz184

Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte MV, 2020, '1133 PANCREATIC STELLATE CELL AND CANCER CELL DERIVED EXOSOMES IMPAIR BETA CELL FUNCTION: IMPLICATIONS FOR PANCREATIC CANCER RELATED DIABETES.', Gastroenterology, 158, pp. S - 221, http://dx.doi.org/10.1016/s0016-5085(20)31245-2

Abdel Shaheed C; Carland JE; Graham GG; Stocker SL; Smith G; Hicks M; Williams KM; Furlong T; Macdonald P; Greenfield JR; Smith FC; Chowdhury G; Day RO, 2019, 'Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis', British Journal of Clinical Pharmacology, 85, pp. 2772 - 2783, http://dx.doi.org/10.1111/bcp.14107

Milder TY; Stocker SL; Samocha-Bonet D; Day RO; Greenfield JR, 2019, 'Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes—cardiovascular and renal benefits in patients with chronic kidney disease', European Journal of Clinical Pharmacology, 75, pp. 1481 - 1490, http://dx.doi.org/10.1007/s00228-019-02732-y

Greenfield JR; Carette C; Czernichow S, 2019, 'Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults', The New England journal of medicine, 381, pp. e17, http://dx.doi.org/10.1056/NEJMc1908751

Snaith JR; Holmes-Walker DJ; Greenfield JR, 2019, 'Association of insulin dose, cardiometabolic risk factors, and cardiovascular disease in type 1 diabetes during 30 years of follow-up in the DCCT/EDIC study. Diabetes care 2019;42:657-664', Diabetes Care, 42, pp. E135 - E136, http://dx.doi.org/10.2337/dc19-0730

Cehic MG; Muir CA; Greenfield JR; Hayward C; Jabbour A; Keogh A; Kotlyar E; Muthiah K; Macdonald PS, 2019, 'Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients', Transplantation Direct, 5, pp. e450, http://dx.doi.org/10.1097/TXD.0000000000000885

Tang A; Coster ACF; Tonks KT; Heilbronn LK; Pocock N; Purtell L; Govendir M; Blythe J; Zhang J; Xu A; Chisholm DJ; Johnson NA; Greenfield JR; Samocha-Bonet D, 2019, 'Longitudinal changes in insulin resistance in normal weight, overweight and obese individuals', Journal of Clinical Medicine, 8, pp. 623, http://dx.doi.org/10.3390/jcm8050623

Muir C; Dwight T; Center J; Greenfield J; Clifton-Bligh R; Lee P, 2019, 'MON-378 Somatic HIF2α Mutation and Pheochromocytoma in a Patient with Cyanotic Congenital Heart Disease', Journal of the Endocrine Society, 3, http://dx.doi.org/10.1210/js.2019-mon-378

Taylor JE; Campbell LV; Greenfield JR, 2019, 'Author reply', Internal Medicine Journal, 49, pp. 552, http://dx.doi.org/10.1111/imj.14255

Snaith JR; Holmes-Walker DJ; Girgis CM; Greenfield JR, 2019, 'Excess mortality and cardiovascular disease risk in type 1 diabetes', The Lancet, 393, pp. 984 - 985, http://dx.doi.org/10.1016/S0140-6736(18)33050-2

Milder TY; Stocker SL; Shaheed CA; McGrath-Cadell L; Samocha-Bonet D; Greenfield JR; Day RO, 2019, 'Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis', JOURNAL OF CLINICAL MEDICINE, 8, http://dx.doi.org/10.3390/jcm8010045

Patel S; Chin V; Greenfield JR, 2019, 'Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism', Endocrinology, Diabetes and Metabolism Case Reports, 2019, http://dx.doi.org/10.1530/EDM-19-0098

Lenders NF; Greenfield JR, 2019, 'Urinary steroid profiling in diagnostic evaluation of an unusual adrenal mass', Endocrinology, Diabetes and Metabolism Case Reports, 2019, http://dx.doi.org/10.1530/EDM-19-0090

Greenfield J, 2019, 'Challenges to obesity research in humans: the power of human phenomic studies', Obesity Research & Clinical Practice, 13, pp. 272 - 272, http://dx.doi.org/10.1016/j.orcp.2018.11.106

Bishay RH; Tonks KT; George J; Samocha-Bonet D; Chisholm DJ; James DE; Greenfield JR, 2019, 'Circulating bile acids are associated with insulin resistance and visceral and liver fat in human subjects', Obesity Research & Clinical Practice, 13, pp. 28 - 29, http://dx.doi.org/10.1016/j.orcp.2016.10.030

Tang A; Tonks KT; Heilbronn LK; Pocock NA; Campbell LV; James DE; Chisholm DJ; Greenfield JR; Samocha-Bonet D, 2019, 'Insulin-sensitive overweight/obese individuals remain as insulin sensitive and normotensive as lean subjects over 6 years', Obesity Research & Clinical Practice, 13, pp. 35 - 35, http://dx.doi.org/10.1016/j.orcp.2016.10.042

Koay YC; Yang P; Chen D; Jenkins AB; Greenfield J; O'Sullvan JF; Samocha-Bonet D, 2019, 'Novel circulating biomarkers identify insulin resistance phenotypes in obesity', Obesity Research & Clinical Practice, 13, pp. 267 - 268, http://dx.doi.org/10.1016/j.orcp.2018.11.092

Back to profile page